A public company based in China has its core businesses in-vitro diagnostics and radiation therapy. The corporate fund of this company is looking to work with early-stage medical device companies using a variety of structures, including equity investments and M&A. The firm is looking to engage in Seed to Series B/C and the average check size is usually less than 10M USD. The firm is open to opportunities worldwide and prefers companies with some sort of China angles. The firm is looking to make 3-4 new investments within the next 12 months.
While the firm’s core business is in IVD and radiation therapy, the firm is interested in medical devices of all classes.
The firm does not have any specific requirements for the company’s management team, but they do prefer companies with a China angle. The firm is open to both leading and co-investing and is likely to take a board seat when leading. The firm looks to be an active investor and strategically collaborate with their portfolio companies to create synergies.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment